RD, H. (2014). Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib. Dove Medical Press.
Chicago Style (17th ed.) CitationRD, Harvey. Incidence and Management of Adverse Events in Patients with Relapsed And/or Refractory Multiple Myeloma Receiving Single-agent Carfilzomib. Dove Medical Press, 2014.
MLA (8th ed.) CitationRD, Harvey. Incidence and Management of Adverse Events in Patients with Relapsed And/or Refractory Multiple Myeloma Receiving Single-agent Carfilzomib. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.